Mitral regurgitation is a cardiac ailment characterized by the retrograde flow of blood from the left ventricle back into the left atrium. The mitral valve, responsible for maintaining the unidirectional flow of blood between these cardiac chambers, fails to close properly during each heartbeat, leading to the regurgitation or leakage of blood. This condition imposes an increased workload on the heart as it endeavors to pump an adequate volume of blood to meet the body's physiological demands. Diverse etiological factors contribute to the development of mitral regurgitation, including mitral valve prolapse, rheumatic heart disease, and congenital anomalies. The manifestation of symptoms often includes fatigue, dyspnea (shortness of breath), and the presence of a discernible heart murmur upon auscultation. An early and accurate diagnosis is imperative for instituting timely interventions, as this can help prevent potential complications associated with untreated mitral regurgitation. In the realm of management, various strategies are employed to address this cardiovascular condition. Medical interventions, including pharmacotherapy, play a crucial role in alleviating symptoms and improving heart function. In instances of severe mitral regurgitation, surgical options such as repair or replacement of the mitral valve may be considered to restore normal cardiac function. The choice of intervention is often tailored to the severity of the condition and the individual patient's health status.
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom